Cite
APA Citation
Brun, M. K., Goll, G. L., Jørgensen, K. K., Sexton, J., Gehin, J. E., Sandanger, Ø., Olsen, I. C., Klaasen, R. A., Warren, D. J., Mørk, C., Kvien, T. K., Jahnsen, J., Bolstad, N., Haavardsholm, E. A., & Syversen, S. W. (2022). risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. Journal of internal medicine, 292, 477–491. http://access.bl.uk/ark:/81055/vdc_100161623340.0x00003b